{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:27:48Z","timestamp":1787146068206,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CHU Saint-\u00c9tienne"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sleep Breath"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Ticagrelor, a reversible P2Y12 inhibitor widely prescribed after acute coronary syndrome (ACS), induces dyspnoea and central sleep apnoea through effects on respiratory centre activity. During cardiac rehabilitation, we observed apparent ventilatory disturbances in patients receiving ticagrelor during cardiopulmonary exercise tests (CPET). This study aimed to evaluate whether ticagrelor significantly increases the risk of periodic breathing during exercise and whether this impairs functional or metabolic performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a single-centre retrospective observational study (October 2012\u2013December 2021) including 84 coronary patients (36 ticagrelor, 48 thienopyridines) who underwent cardiac rehabilitation following angioplasty with coronary stenting. The primary endpoint was exercise-induced periodic breathing, defined as \u2265\u20093 consecutive oscillation cycles of VE, VO2, or VCO2 with amplitude\u2009\u2265\u200930% of mean values. Secondary endpoints were peak VO2, end-tidal CO2 pressure (PETCO2), and ventilatory equivalent for CO2 (EqCO2) at peak VO2. Univariable and multivariable logistic and linear regression analyses were performed (R v4.0.0).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Ticagrelor was independently associated with a\u2009&gt;\u20097-fold increased risk of periodic breathing during exercise in both univariable (OR\u2009=\u20097.82, 95% CI [2.80\u201324.72],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and multivariable analyses (OR\u2009=\u20097.17, 95% CI [2.31\u201325.19],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), after adjustment for age, BMI, LVEF, smoking, obstructive lung disease, and neurological risk. No significant effect on PETCO2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.759) or EqCO2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.442) at peak VO2 was observed. In multivariable analysis, patients on ticagrelor had significantly higher peak VO2 than those on thienopyridines (+\u20093.17\u00a0ml\/min\/kg, 95% CI [1.34\u20134.99],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Ticagrelor is significantly associated with periodic breathing during exercise in coronary patients undergoing cardiac rehabilitation. However, this ventilatory disturbance does not impair gas exchange or aerobic capacity. These findings support maintaining ticagrelor therapy in patients presenting with exercise-induced periodic breathing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11325-026-03737-5","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:35:28Z","timestamp":1784039728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ticagrelor is associated with periodic breathing during exercise in coronary patients undergoing cardiac rehabilitation: a retrospective observational study"],"prefix":"10.1007","volume":"30","author":[{"given":"Simon","family":"Pointel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Delavenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bonjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Mismetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Vergnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Froudarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Isaaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-7958","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"3737_CR1","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1160\/TH12-08-0547","volume":"108","author":"M Cattaneo","year":"2012","unstructured":"Cattaneo M, Faioni E (2012) Why does ticagrelor induce dyspnea? Thromb Haemost 108:1031\u20131036","journal-title":"Thromb Haemost"},{"key":"3737_CR2","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045\u20131057","journal-title":"N Engl J Med"},{"issue":"Suppl 6","key":"3737_CR3","first-page":"S75","volume":"105","author":"R Storey","year":"2011","unstructured":"Storey R (2011) Pharmacology and clinical trials of reversibly-binding P2Y12 inhibitors. Thromb Haemost 105(Suppl 6):S75\u2013S81","journal-title":"Thromb Haemost"},{"key":"3737_CR4","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","volume":"27","author":"S Husted","year":"2006","unstructured":"Husted S, Emanuelsson H, Heptinstall S et al (2006) Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin. Eur Heart J 27:1038\u20131047","journal-title":"Eur Heart J"},{"key":"3737_CR5","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s40262-015-0290-2","volume":"54","author":"R Teng","year":"2015","unstructured":"Teng R (2015) Ticagrelor: pharmacokinetic, pharmacodynamic and pharmacogenetic profile: an update. Clin Pharmacokinet 54:1125\u20131138","journal-title":"Clin Pharmacokinet"},{"key":"3737_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.sleep.2021.01.026","volume":"80","author":"P Meurin","year":"2021","unstructured":"Meurin P, Ben Driss A, Defrance C et al (2021) Central sleep apnea after acute coronary syndrome and association with ticagrelor use. Sleep Med 80:39\u201345","journal-title":"Sleep Med"},{"key":"3737_CR7","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/j.jacc.2018.03.447","volume":"71","author":"B Revol","year":"2018","unstructured":"Revol B, Jullian-Desayes I, Tamisier R et al (2018) Ticagrelor and central sleep apnea. J Am Coll Cardiol 71:2378\u20132379","journal-title":"J Am Coll Cardiol"},{"key":"3737_CR8","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","volume":"372","author":"MP Bonaca","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M et al (2015) Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med 372:1791\u20131800","journal-title":"N Engl J Med"},{"key":"3737_CR9","doi-asserted-by":"publisher","first-page":"H72","DOI":"10.1152\/ajpheart.00470.2016","volume":"313","author":"V Adams","year":"2017","unstructured":"Adams V, Reich B, Uhlemann M, Niebauer J (2017) Molecular effects of exercise training in patients with cardiovascular disease: focus on skeletal muscle, endothelium, and myocardium. Am J Physiol Heart Circ Physiol 313:H72\u2013H88","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3737_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuroscience.2004.05.003","volume":"127","author":"H Franke","year":"2004","unstructured":"Franke H, Kr\u00fcgel U, Grosche J et al (2004) P2Y receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience 127:431\u2013441","journal-title":"Neuroscience"},{"key":"3737_CR11","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/nn1805","volume":"9","author":"SE Haynes","year":"2006","unstructured":"Haynes SE, Hollopeter G, Yang G et al (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9:1512\u20131519","journal-title":"Nat Neurosci"},{"key":"3737_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1126\/science.1190721","volume":"329","author":"AV Gourine","year":"2010","unstructured":"Gourine AV, Kasymov V, Marina N et al (2010) Astrocytes control breathing through pH-dependent release of ATP. Science 329:571\u2013575","journal-title":"Science"},{"key":"3737_CR13","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.jacc.2014.03.031","volume":"63","author":"M Cattaneo","year":"2014","unstructured":"Cattaneo M, Schulz R, Nylander S (2014) Adenosine-mediated effects of ticagrelor. J Am Coll Cardiol 63:2503\u20132509","journal-title":"J Am Coll Cardiol"},{"key":"3737_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0034-5687(00)00204-8","volume":"125","author":"LY Lee","year":"2001","unstructured":"Lee LY, Pisarri TE (2001) Afferent properties and reflex functions of bronchopulmonary C-fibers. Respir Physiol 125:47\u201365","journal-title":"Respir Physiol"},{"key":"3737_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.sleep.2007.06.012","volume":"9","author":"F Roche","year":"2008","unstructured":"Roche F, Maudoux D, Jamon Y, Barthelemy JC (2008) Monitoring of ventilation during the early part of cardiopulmonary exercise testing: the first step to detect central sleep apnoea in chronic heart failure. Sleep Med 9:411\u2013417","journal-title":"Sleep Med"},{"key":"3737_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1051\/medsci\/20021810965","volume":"18","author":"JM Boeynaems","year":"2002","unstructured":"Boeynaems JM, Communi D, Suarez Gonzalez N et al (2002) Les r\u00e9cepteurs P2Y des nucl\u00e9otides extracellulaires: du clonage \u00e0 la physiologie. Med Sci (Paris) 18:965\u2013973","journal-title":"Med Sci (Paris)"},{"key":"3737_CR17","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/bcp.13967","volume":"85","author":"V Puel","year":"2019","unstructured":"Puel V, Th\u00e9ophile H, Godard I et al (2019) Ticagrelor and central sleep apnoea: impact of withdrawal and reintroduction. Br J Clin Pharmacol 85:1855\u20131858","journal-title":"Br J Clin Pharmacol"},{"key":"3737_CR18","first-page":"104","volume":"48","author":"C Ren","year":"2020","unstructured":"Ren C, Zhao W, Shen T et al (2020) Effects of ticagrelor on cardiorespiratory fitness in patients after percutaneous coronary intervention. Zhonghua xin xue guan bing za zhi 48:104\u2013110","journal-title":"Zhonghua xin xue guan bing za zhi"},{"key":"3737_CR19","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.ijcard.2014.07.216","volume":"176","author":"H Wu","year":"2014","unstructured":"Wu H, Wang Q, Zhou J, Qian J, Ge J (2014) First report of stent thrombosis after a switch therapy resulting from ticagrelor-related dyspnea. Int J Cardiol 176:e127\u2013e128","journal-title":"Int J Cardiol"},{"key":"3737_CR20","first-page":"831e9","volume":"33","author":"D Alexopoulos","year":"2017","unstructured":"Alexopoulos D, Lekakis J (2017) Dyspnea attributed to ticagrelor: variable tolerability in different clinical settings. Can J Cardiol 33:831e9\u2013831e10","journal-title":"Can J Cardiol"},{"key":"3737_CR21","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1093\/eurheartj\/ehr231","volume":"32","author":"RF Storey","year":"2011","unstructured":"Storey RF, Becker RC, Harrington RA et al (2011) Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. Eur Heart J 32:2945\u20132953","journal-title":"Eur Heart J"},{"key":"3737_CR22","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJMc1601662","volume":"375","author":"A Giannoni","year":"2016","unstructured":"Giannoni A, Emdin M, Passino C (2016) Cheyne\u2013Stokes respiration, chemoreflex, and ticagrelor-related dyspnea. N Engl J Med 375:1004\u20131006","journal-title":"N Engl J Med"},{"key":"3737_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijcard.2014.02.028","volume":"173","author":"M Gaubert","year":"2014","unstructured":"Gaubert M, Laine M, Richard T et al (2014) Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients. Int J Cardiol 173:120\u2013121","journal-title":"Int J Cardiol"},{"key":"3737_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.sleep.2017.09.033","volume":"43","author":"V Lamberts","year":"2018","unstructured":"Lamberts V, Baele P, Kahn D, Liistro G (2018) Dyspnea or Cheyne\u2013Stokes respiration associated with ticagrelor? Sleep Med 43:4\u20136","journal-title":"Sleep Med"}],"container-title":["Sleep and Breathing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-026-03737-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11325-026-03737-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-026-03737-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:59:16Z","timestamp":1787144356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11325-026-03737-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3737"],"URL":"https:\/\/doi.org\/10.1007\/s11325-026-03737-5","relation":{},"ISSN":["1520-9512","1522-1709"],"issn-type":[{"value":"1520-9512","type":"print"},{"value":"1522-1709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was granted by the \u2018Terre d\u2019Ethique\u2019 Committee of the University Hospital of Saint-Etienne (Ref: IRBN892021\/CHUSTE).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"216"}}